Intranasal dexmedetomidine administration in clinically recommended doses has a small but important risk of causing catastrophic respiratory failure in the setting of preexisting severe respiratory workloads.
Keywords: critical care medicine; pediatric and adolescent medicine; respiratory medicine; toxicology.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.